FOSTER CITY, Calif. - Gilead Sciences, Inc. (NASDAQ:GILD), a biopharmaceutical firm with a market capitalization of $119.87 billion, announced today a 2.6% increase in its quarterly cash dividend.

If you need to generate income from your investments, selecting securities or funds based on their current interest or dividend payouts might solve the immediate problem. But a strategy of increasing ...

For example, the recent F share price of $9.24 represents a price-to-book ratio of 0.8 and an annual dividend yield of 6.49% ...

The stock looks like a decent value, but it could be a bargain if management can execute. Its dividend checks all the boxes ...

Dividend growth investing is a proven, low-risk strategy for building wealth. Check out my four dividend growth stock picks ...

The company's announcement that it was walking back its 2028 goals for smoke-free products warranted a closer look at its ...

Eliquis, a blood thinner marketed in partnership with Bristol Myers Squibb, is Pfizer's largest revenue stream at the moment.

Richelieu Hardware's estimated fair value is CA$38.29 based on 2 Stage Free Cash Flow to Equity. Current share price of CA$39.28 suggests Richelieu Hardware is poten ...

This high-quality Canadian dividend stock offers an attractive yield and plenty of long-term growth potential.

(Reuters) - Netflix is considering a bid for Formula One's U.S. TV rights, according to a report from The Athletic on Friday.

Key Insights The projected fair value for Thakral is S$0.91 based on Dividend Discount Model Current share price ...

These three stocks offer significant and reliable monthly dividends, making them among the best investments to buy for ...